Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$9.10 +0.79 (+9.51%)
At close: Sep 30, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Preferred Shares (2023 - 2025)

Updated

Eupraxia Pharmaceuticals (EPRX) reported Preferred Shares of $29.74 million for the quarter ended Dec 31, 2025, down 6.2% from $31.71 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Preferred Shares (2023 - 2025) Analysis & Trends

  • By year, Preferred Shares came in at $31.71 million in the year ended Dec 31, 2024 (unchanged) and $31.71 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 29.74 Mn
Dec 31, 2024 31.71 Mn
Dec 31, 2023 31.71 Mn
API Access

Eupraxia Pharmaceuticals Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=EPRX&period=max&api_key=YOUR_API_KEY